Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes-Reference-Cited by-同舟云学术

Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes

Published:2014-03 Issue: Volume:178 Page:101-107
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Graham Susan M.,Carlisle Robert,Choi James J.,Stevenson Mark,Shah Apurva R.,Myers Rachel S.,Fisher Kerry,Peregrino Miriam-Bazan,Seymour Len^ORCID,Coussios Constantin C.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference37 articles.

1. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting;Maeda;Adv. Enzyme Regul.,2001

2. Doxil(R)–the first FDA-approved nano-drug: lessons learned;Barenholz;J. Control. Release,2012

3. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma;Coukell;Drugs,1997

4. Effect of pazopanib on tumor microenvironment and liposome delivery;Tailor;Mol. Cancer Ther.,2010

5. Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors;Laginha;Clin. Cancer Res.,2005

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Ultrasound-Based Therapies in Cardiovascular Diseases;Structural Heart;2024-07

2. Regulation of IFP in solid tumours through acoustic pressure to enhance infiltration of nanoparticles of various sizes;Journal of Drug Targeting;2024-06-24

3. Smart liposome technology for drug delivery of bioactives;Progress and Prospect of Nanocarriers;2024

4. Bioreducible exosomes encapsulating glycolysis inhibitors potentiate mitochondria-targeted sonodynamic cancer therapy via cancer-targeted drug release and cellular energy depletion;Biomaterials;2023-10

5. Cavitation-Mediated Immunomodulation and Its Use with Checkpoint Inhibitors;Pharmaceutics;2023-08-09